Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Federal Valid Rx Standard Would Help Control Internet Pharmacies, FDA Says

Executive Summary

A federal standard defining what constitutes a "valid prescription" would aid FDA enforcement efforts against illegal drug sales through Internet pharmacies, FDA Associate Commissioner for Regulatory Affairs John Taylor told the House Government Reform Committee March 27

You may also be interested in...



FDA Import Policy Discourages Promotion, Not Reimbursement – McClellan

FDA's letter to health insurers about drug importation is meant to ensure they do not encourage policy holders to purchase drugs from outside the U.S., not to prohibit them from covering individuals who purchase Canadian drugs for personal use, FDA Commissioner McClellan told a Senate Appropriations/Agriculture Subcommittee hearing May 22

FDA Import Policy Discourages Promotion, Not Reimbursement – McClellan

FDA's letter to health insurers about drug importation is meant to ensure they do not encourage policy holders to purchase drugs from outside the U.S., not to prohibit them from covering individuals who purchase Canadian drugs for personal use, FDA Commissioner McClellan told a Senate Appropriations/Agriculture Subcommittee hearing May 22

FDA, Pharmacy Group Discussing Canadian Rxs; NCPA Wants To Ban Ads

The National Community Pharmacists Association plans to discuss the possibility of warning media outlets against running ads promoting Canadian drugs during an upcoming meeting with FDA Commissioner McClellan

Related Content

UsernamePublicRestriction

Register

OM005224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel